Based on WHO | If I have melanoma, why might I develop shortness of breath, and when should I seek emergency care?

Shortness of breath (dyspnea) in someone with melanoma can have several possible causes, ranging from cancer spread to the lungs or pleura to treatment‑related side effects or blood clots, and some of these situations need urgent care. In general, any new, worsening, or severe shortness of breath, especially with chest pain, fever, coughing up blood, or fainting, should prompt immediate medical attention. ^{[1] [2]}

---

Common Causes of Shortness of Breath in Melanoma

• Pulmonary metastases (spread to the lungs): Melanoma can travel to the lungs, leading to symptoms like persistent cough, chest discomfort, and shortness of breath. Fluid can also collect around the lungs (pleural effusion), making breathing difficult or painful, particularly with deep breaths. ^{[1] [3]}
  Pleural effusion from cancer often recurs and may need procedures to drain the fluid or prevent it from coming back. Removing fluid (thoracentesis) can relieve breathlessness and improve oxygen levels when effusions are large. ^{[4] [5]}

• Malignant pleural effusion (cancer‑related fluid around the lungs): This can occur even without a visible lung mass and present primarily as shortness of breath. Management typically includes drainage and, when needed, pleurodesis or placement of a tunneled pleural catheter to prevent recurrent fluid. ^{[4] [5]}

• Pulmonary embolism (PE, blood clot in the lungs): People with cancer have a higher risk of clots, which can suddenly cause shortness of breath, chest pain, fast heartbeat, dizziness, or collapse. PE can be life‑threatening but treatable; prompt diagnosis and anticoagulation reduce mortality. ^[6]
  PE may be missed if symptoms are attributed to cancer; guidelines generally treat incidentally discovered PE similarly to symptomatic PE. If you develop sudden shortness of breath or chest pain, this is an emergency. ^{[7] [2]}

• Treatment‑related lung inflammation or toxicity: Some melanoma therapies (e.g., immunotherapy or targeted therapy) can inflame lung tissue and cause cough, fever, wheeze, chest pain, and dyspnea. Shortness of breath during or after treatment should be reported immediately, as lung side effects can be serious. ^{[8] [9] [10]}

• Cardiac metastases or involvement: Melanoma can rarely spread to the heart, potentially causing breathlessness, chest symptoms, or abnormal rhythms; multimodal imaging (echo, CT, MRI, PET) helps detect this. While uncommon, heart involvement can present with shortness of breath and warrants urgent evaluation if suspected. ^[11]

---

When Shortness of Breath Is an Emergency

Seek urgent care (Emergency Department or call emergency services) if you have any of the following:

• Sudden or rapidly worsening shortness of breath. ^[2]
• Chest pain, tightness, or pressure. ^[2]
• Fast heartbeat, dizziness, fainting, or confusion. ^[8]
• Fever, dry cough, wheezing, or new oxygen needs while on cancer therapy. ^{[9] [10]}
• Coughing up blood. ^[1]
• Signs suggesting blood clots (pain, redness, swelling in an arm or leg) plus shortness of breath or chest pain. These can indicate a pulmonary embolism. ^{[12] [6]}

Cancer care teams often advise going directly to the Emergency Department if shortness of breath occurs during treatment, especially with chest pain or fever. This advice applies across many oncology regimens because lung complications can escalate quickly. ^{[2] [13] [14]}

---

How Doctors Evaluate Shortness of Breath in Melanoma

• History and exam: Timeline, triggers, associated symptoms (fever, chest pain, leg swelling), and current therapies can point toward infection, PE, effusion, or drug‑related lung inflammation. Medication review is critical because some treatments carry lung risks. ^{[8] [9]}

• Imaging:

  • Chest X‑ray/CT: Checks for lung nodules, pneumonia, or pleural effusion. CT can also reveal pulmonary embolism. ^[6]
  • Ultrasound of the chest: Rapidly confirms pleural effusion at the bedside. It guides safe fluid drainage when needed. ^[4]
  • Echocardiography: Evaluates heart function and looks for cardiac masses if heart involvement is suspected. Cardiac imaging helps identify rare metastases to the heart. ^[11]

• Laboratory tests:

  • D‑dimer and blood tests: May be used in assessing clot risk, although interpretation differs in cancer. Definitive diagnosis of PE relies on imaging. ^[6]
  • Pleural fluid cytology: If fluid is present, cytology can confirm malignant cells. A positive cytology supports malignant pleural effusion and guides management. ^[4]

---

Treatment Options Depend on the Cause

• Pulmonary metastases: Systemic therapy for melanoma (immunotherapy, targeted therapy where appropriate) is the cornerstone. Breathlessness due to large masses or airway issues may need supplemental oxygen, bronchoscopy, or palliative approaches. ^{[9] [10]}

• Malignant pleural effusion:

  • Thoracentesis for immediate relief and diagnosis. If fluid recurs, pleurodesis or a tunneled pleural catheter provides longer‑term control. ^{[4] [5]}
  • Oncologic therapy tailored to melanoma to reduce fluid production. Procedural choice depends on recurrence, performance status, and goals of care. ^[5]

• Pulmonary embolism:

  • Anticoagulation is typically started unless bleeding risk is prohibitive. Massive or unstable PE may require thrombolysis or surgical intervention. ^[6]
  • Incidentally found PE in cancer generally receives similar treatment to symptomatic PE. Close follow‑up is essential due to recurrence risk. ^[7]

• Treatment‑related lung toxicity:

  • Immediate therapy hold and medical assessment. Steroids or other measures may be needed depending on severity. ^{[8] [9]}
  • Prompt reporting of new respiratory symptoms helps prevent serious complications. Monitoring of lung function during treatment is standard. ^[10]

---

Practical Tips for Monitoring and Prevention

• Track symptoms carefully: Note onset, triggers (exertion vs. rest), associated fever, chest pain, or leg swelling. Early recognition of patterns can speed diagnosis. ^[1]
• Know your therapy risks: Ask your team whether your current melanoma treatment carries lung or clot risks and what warning signs to watch for. Many programs advise immediate reporting of chest pain or new breathlessness. ^{[2] [14]}
• Prepare an emergency plan: Keep contact numbers and know the nearest Emergency Department. If you develop severe shortness of breath, do not drive yourself call emergency services. ^[2]

---

Summary

Shortness of breath in melanoma can stem from lung metastases, pleural fluid buildup, blood clots, or treatment‑related lung problems. Because some causes are urgent or life‑threatening, new or worsening breathlessness especially with chest pain, fever, coughing up blood, fainting, or rapid heart rate should prompt immediate emergency care. ^{[1] [2] [6] [9] [10]}